I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
An arginase1- and PD-L1-derived peptide-based vaccine for m..:
Jacob Handlos Grauslund
;
Morten Orebo Holmström
;
Evelina Martinenaite
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1117466/full. , 2023
Link:
https://doi.org/10.3389/fimmu.2023.1117466
RT Journal T1
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:5bb1896ca9234691adc0750d751600e6&Exemplar=1&LAN=DE A1 Jacob Handlos Grauslund A1 Morten Orebo Holmström A1 Evelina Martinenaite A1 Thomas Landkildehus Lisle A1 Hannah Jorinde Glöckner A1 Daniel El Fassi A1 Uffe Klausen A1 Rasmus E. J. Mortensen A1 Nicolai Jørgensen A1 Lasse Kjær A1 Vibe Skov A1 Inge Marie Svane A1 Hans Carl Hasselbalch A1 Mads Hald Andersen PB Frontiers Media S.A. YR 2023 K1 myeloproliferative neoplasms K1 cancer immune therapy K1 arginase-1 K1 PD-L1 K1 immune modulatory vaccines K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1117466/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1117466 DO https://doi.org/10.3389/fimmu.2023.1117466 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)